Bausch Health Companies | VRX - Pre Tax Profit

Stock Price
7.38
Daily Change
0.07 0.96%
Monthly
1.79%
Yearly
4.38%
Q2 Forecast
7.29

Bausch Health Companies reported $218M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Amgen USD 3.92B 2.35B Sep/2025
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Aurora Cannabis CAD -1.58M 48.55M Dec/2025
Bausch Health Companies USD 218M 78M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Canopy Growth CAD -62.26M 60.84M Dec/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Danaher USD 1.08B 421M Sep/2025
Drreddys Laboratories INR 15.43B 1.96B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Pacira USD 9.52M 11.45M Sep/2025
Perrigo USD 22.4M 19.2M Sep/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 69.13M 7.35M Sep/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Zoetis USD 887M 15M Sep/2025